Title:
【発明の名称】MHC分子HLA-C-クローン10と複合体を形成する分離されたペプチドとその利用方法
Document Type and Number:
Japanese Patent JP3477523
Kind Code:
B2
Abstract:
A family of tumor rejection antigen precursors, and the nucleic acid molecules which code for them, are disclosed. These tumor rejection antigen precursors are referred to as BAGE tumor rejection antigen precursors, and the nucleic acid molecules which code for them are referred to as BAGE coding molecules. Various diagnostic and therapeutic uses of the coding sequences and the tumor rejection antigen precursor molecules are described.
Inventors:
Van der burggen, pierre
Boone-Farrer, Thierry
Courier, Pierre
Renault, Jean-Christophe
Boone-Farrer, Thierry
Courier, Pierre
Renault, Jean-Christophe
Application Number:
JP50288095A
Publication Date:
December 10, 2003
Filing Date:
June 10, 1994
Export Citation:
Assignee:
Ludwig Institute for Cancer Research
International Classes:
A61K38/00; A61P35/00; C07H21/02; C07H21/04; C07K7/06; C07K7/08; C07K14/47; C12N15/09; C07K14/74; C12N1/21; C12N5/10; C12N15/12; C12P21/02; C12R1/91; (IPC1-7): C12N15/09; A61K38/00; A61P35/00; C07K7/06; C07K7/08; C07K14/47; C12N5/10
Other References:
【文献】国際公開92/020356(WO,A1)
Attorney, Agent or Firm:
Shuichiro Kitamura
Previous Patent: TAPE MEASURE
Next Patent: ROTATIONAL LOSS MEASURING DEVICE OF SUPERCONDUCTING BEARING PART
Next Patent: ROTATIONAL LOSS MEASURING DEVICE OF SUPERCONDUCTING BEARING PART